Universe Pharmaceuticals INC (UPC)
NASDAQ: UPC · Real-Time Price · USD
3.990
+0.010 (0.25%)
Feb 9, 2026, 12:30 PM EST - Market open

UPC Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
22631254
Market Cap Growth
103.61%-58.99%66.62%-71.82%-77.13%-
Enterprise Value
-22-371-19-1220
Last Close Price
3.984.20146.40570.002034.008891.99
PE Ratio
-----4.75
PS Ratio
0.100.130.250.110.311.12
PB Ratio
0.040.040.130.120.270.91
P/TBV Ratio
0.040.040.130.120.270.91
P/FCF Ratio
---3.23--
P/OCF Ratio
---3.10--
EV/Sales Ratio
--0.04--0.43
EV/EBITDA Ratio
-----1.46
EV/EBIT Ratio
-----1.51
Debt / Equity Ratio
0.170.170.180.200.090.07
Debt / EBITDA Ratio
-----0.31
Debt / FCF Ratio
---5.11--
Asset Turnover
0.260.260.420.640.620.97
Inventory Turnover
3.123.125.607.937.8210.37
Quick Ratio
3.553.552.331.332.603.36
Current Ratio
4.074.072.541.843.174.50
Return on Equity (ROE)
-7.23%-7.23%-23.76%-17.69%-15.01%28.39%
Return on Assets (ROA)
-2.66%-2.66%-9.14%-4.90%-6.77%17.17%
Return on Invested Capital (ROIC)
-9.17%-10.45%-30.75%-13.29%-19.24%41.01%
Return on Capital Employed (ROCE)
-5.20%-5.20%-16.80%-14.20%-15.10%23.10%
Earnings Yield
-163.78%-155.20%-151.27%-190.05%-64.37%21.07%
FCF Yield
-237.24%-224.81%-169.04%30.98%-11.36%-29.02%
Buyback Yield / Dilution
-3174.93%-3174.93%----
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q